10-K Filing

UNITEDHEALTH GROUP INC CIK: 731766 FY 2023

Filing Information

Form Type	10-K
Accession Number	`0000731766-24-000081`
Period End Date	20231231
Filing Date	20240228
Fiscal Year	2023
Fiscal Period	FY
XBRL Instance	unh-20231231_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 94 Income Statement 63 Cash Flow Statement 111 Stockholders Equity 51 Comprehensive Income 36

Balance Sheet 94 line items

Line Item	Tag	Value	Unit	Period
Allowance for doubtful accounts, accounts receivable	`AllowanceForDoubtfulAccountsReceivableCurrent`	$877.00M	USD	Point-in-time
Allowance for doubtful accounts, accounts receivable	`AllowanceForDoubtfulAccountsReceivableCurrent`	$1.00B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$25.43B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$23.36B	USD	Point-in-time
Short-term investments	`ShortTermInvestments`	$4.20B	USD	Point-in-time
Allowance for doubtful accounts, other receivables	`AllowanceForDoubtfulOtherReceivablesCurrent`	$2.08B	USD	Point-in-time
Short-term investments	`ShortTermInvestments`	$4.55B	USD	Point-in-time
Allowance for doubtful accounts, other receivables	`AllowanceForDoubtfulOtherReceivablesCurrent`	$1.43B	USD	Point-in-time
Accounts receivable, net of allowances of $1,000 and $877	`AccountsReceivableNetCurrent`	$21.28B	USD	Point-in-time
Accounts receivable, net of allowances of $1,000 and $877	`AccountsReceivableNetCurrent`	$17.68B	USD	Point-in-time
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$7.04B	USD	Point-in-time
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$6.93B	USD	Point-in-time
Finite-lived Intangible Assets, Accumulated Amortization	`FiniteLivedIntangibleAssetsAccumulatedAmortization`	$7.28B	USD	Point-in-time
Finite-lived Intangible Assets, Accumulated Amortization	`FiniteLivedIntangibleAssetsAccumulatedAmortization`	$6.14B	USD	Point-in-time
Other current receivables, net of allowances of $2,084 and $1,433	`OtherReceivablesNetCurrent`	$12.77B	USD	Point-in-time
Other current receivables, net of allowances of $2,084 and $1,433	`OtherReceivablesNetCurrent`	$17.69B	USD	Point-in-time
Assets under management	`AarpAssetsUnderManagement`	$3.75B	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Assets under management	`AarpAssetsUnderManagement`	$4.09B	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$6.62B	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$6.08B	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Total current assets	`AssetsCurrent`	$78.44B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$69.07B	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Long-term investments	`LongTermInvestments`	$47.61B	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Long-term investments	`LongTermInvestments`	$43.73B	USD	Point-in-time
Property, equipment and capitalized software, net of accumulated depreciation and amortization of $7,039 and $6,930	`PropertyPlantAndEquipmentNet`	$11.45B	USD	Point-in-time
Property, equipment and capitalized software, net of accumulated depreciation and amortization of $7,039 and $6,930	`PropertyPlantAndEquipmentNet`	$10.13B	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Goodwill	`Goodwill`	$93.35B	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	3.00B	shares	Point-in-time
Goodwill	`Goodwill`	$75.80B	USD	Point-in-time
Goodwill	`Goodwill`	$103.73B	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	3.00B	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	934.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	924.00M	shares	Point-in-time
Other intangible assets, net of accumulated amortization of $7,279 and $6,137	`IntangibleAssetsNetExcludingGoodwill`	$15.19B	USD	Point-in-time
Other intangible assets, net of accumulated amortization of $7,279 and $6,137	`IntangibleAssetsNetExcludingGoodwill`	$14.40B	USD	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	924.00M	shares	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	934.00M	shares	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$15.03B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$17.30B	USD	Point-in-time
Total assets	`Assets`	$273.72B	USD	Point-in-time
Total assets	`Assets`	$245.71B	USD	Point-in-time
Total assets	`Assets`	$212.21B	USD	Point-in-time
Medical costs payable	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$29.06B	USD	Point-in-time
Medical costs payable	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$24.48B	USD	Point-in-time
Medical costs payable	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$21.87B	USD	Point-in-time
Medical costs payable	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$32.40B	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$31.96B	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$27.71B	USD	Point-in-time
Short-term borrowings and current maturities of long-term debt	`DebtCurrent`	$4.27B	USD	Point-in-time
Short-term borrowings and current maturities of long-term debt	`DebtCurrent`	$3.11B	USD	Point-in-time
Unearned revenues	`DeferredRevenueCurrent`	$3.35B	USD	Point-in-time
Unearned revenues	`DeferredRevenueCurrent`	$3.08B	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$26.28B	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$27.07B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$99.05B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$89.24B	USD	Point-in-time
Long-term debt, less current maturities	`LongTermDebtNoncurrent`	$54.51B	USD	Point-in-time
Long-term debt, less current maturities	`LongTermDebtNoncurrent`	$58.26B	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$3.02B	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$2.77B	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$14.46B	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$12.84B	USD	Point-in-time
Total liabilities	`Liabilities`	$159.36B	USD	Point-in-time
Total liabilities	`Liabilities`	$174.80B	USD	Point-in-time
Commitments and contingencies (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Redeemable noncontrolling interests	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$4.90B	USD	Point-in-time
Redeemable noncontrolling interests	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$4.50B	USD	Point-in-time
Preferred stock, $0.001 par value - 10 shares authorized; no shares issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.001 par value - 10 shares authorized; no shares issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.01 par value - 3,000 shares authorized; 924 and 934 issued and outstanding	`CommonStockValue`	$9.00M	USD	Point-in-time
Common stock, $0.01 par value - 3,000 shares authorized; 924 and 934 issued and outstanding	`CommonStockValue`	$9.00M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$86.16B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$95.77B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-8.39B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-7.03B	USD	Point-in-time
Nonredeemable noncontrolling interests	`MinorityInterest`	$3.68B	USD	Point-in-time
Nonredeemable noncontrolling interests	`MinorityInterest`	$5.67B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$68.33B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$81.45B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$94.42B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$75.05B	USD	Point-in-time
Total liabilities, redeemable noncontrolling interests and equity	`LiabilitiesAndStockholdersEquity`	$273.72B	USD	Point-in-time
Total liabilities, redeemable noncontrolling interests and equity	`LiabilitiesAndStockholdersEquity`	$245.71B	USD	Point-in-time

Income Statement 63 line items

Line Item	Tag	Value	Unit	Period
Premiums	`PremiumsEarnedNet`	$290.83B	USD	Annual
Premiums	`PremiumsEarnedNet`	$226.23B	USD	Annual
Premiums	`PremiumsEarnedNet`	$257.16B	USD	Annual
Investment and other income	`InvestmentIncomeInterestAndDividend`	$2.03B	USD	Annual
Investment and other income	`InvestmentIncomeInterestAndDividend`	$2.32B	USD	Annual
Investment and other income	`InvestmentIncomeInterestAndDividend`	$4.09B	USD	Annual
Total revenues	`Revenues`	$371.62B	USD	Annual
Total revenues	`Revenues`	$324.16B	USD	Annual
Total revenues	`Revenues`	$287.60B	USD	Annual
Medical costs	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$210.84B	USD	Annual
Medical costs	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$241.89B	USD	Annual
Medical costs	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$186.91B	USD	Annual
Operating costs	`SellingGeneralAndAdministrativeExpense`	$47.78B	USD	Annual
Operating costs	`SellingGeneralAndAdministrativeExpense`	$42.58B	USD	Annual
Operating costs	`SellingGeneralAndAdministrativeExpense`	$54.63B	USD	Annual
Cost of products sold	`CostOfGoodsAndServicesSold`	$31.03B	USD	Annual
Cost of products sold	`CostOfGoodsAndServicesSold`	$38.77B	USD	Annual
Cost of products sold	`CostOfGoodsAndServicesSold`	$33.70B	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$3.97B	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$3.40B	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$3.10B	USD	Annual
Total operating costs	`CostsAndExpenses`	$295.73B	USD	Annual
Total operating costs	`CostsAndExpenses`	$339.26B	USD	Annual
Total operating costs	`CostsAndExpenses`	$263.63B	USD	Annual
Earnings from operations	`OperatingIncomeLoss`	$23.97B	USD	Annual
Earnings from operations	`OperatingIncomeLoss`	$28.43B	USD	Annual
Earnings from operations	`OperatingIncomeLoss`	$32.36B	USD	Annual
Interest expense	`InterestExpense`	$2.09B	USD	Annual
Interest expense	`InterestExpense`	$1.66B	USD	Annual
Interest expense	`InterestExpense`	$3.25B	USD	Annual
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$29.11B	USD	Annual
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$22.31B	USD	Annual
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$26.34B	USD	Annual
Provision for income taxes	`IncomeTaxExpenseBenefit`	$5.70B	USD	Annual
Provision for income taxes	`IncomeTaxExpenseBenefit`	$5.97B	USD	Annual
Provision for income taxes	`IncomeTaxExpenseBenefit`	$4.58B	USD	Annual
Net earnings	`ProfitLoss`	$17.73B	USD	Annual
Net earnings	`ProfitLoss`	$20.64B	USD	Annual
Net earnings	`ProfitLoss`	$23.14B	USD	Annual
Earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$763.00M	USD	Annual
Earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$447.00M	USD	Annual
Earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$519.00M	USD	Annual
Net earnings attributable to UnitedHealth Group common shareholders	`NetIncomeLoss`	$22.38B	USD	Annual
Net earnings attributable to UnitedHealth Group common shareholders	`NetIncomeLoss`	$20.12B	USD	Annual
Net earnings attributable to UnitedHealth Group common shareholders	`NetIncomeLoss`	$17.29B	USD	Annual
Basic	`EarningsPerShareBasic`	$21.47	USD	Annual
Basic	`EarningsPerShareBasic`	$18.33	USD	Annual
Basic	`EarningsPerShareBasic`	$24.12	USD	Annual
Diluted	`EarningsPerShareDiluted`	$23.86	USD	Annual
Diluted	`EarningsPerShareDiluted`	$21.18	USD	Annual
Diluted	`EarningsPerShareDiluted`	$18.08	USD	Annual
Basic weighted-average number of common shares outstanding	`WeightedAverageNumberOfSharesOutstandingBasic`	943.00M	shares	Annual
Basic weighted-average number of common shares outstanding	`WeightedAverageNumberOfSharesOutstandingBasic`	928.00M	shares	Annual
Basic weighted-average number of common shares outstanding	`WeightedAverageNumberOfSharesOutstandingBasic`	937.00M	shares	Annual
Dilutive effect of common share equivalents	`WeightedAverageNumberDilutedSharesOutstandingAdjustment`	13.00M	shares	Annual
Dilutive effect of common share equivalents	`WeightedAverageNumberDilutedSharesOutstandingAdjustment`	13.00M	shares	Annual
Dilutive effect of common share equivalents	`WeightedAverageNumberDilutedSharesOutstandingAdjustment`	10.00M	shares	Annual
Diluted weighted-average number of common shares outstanding	`WeightedAverageNumberOfDilutedSharesOutstanding`	938.00M	shares	Annual
Diluted weighted-average number of common shares outstanding	`WeightedAverageNumberOfDilutedSharesOutstanding`	950.00M	shares	Annual
Diluted weighted-average number of common shares outstanding	`WeightedAverageNumberOfDilutedSharesOutstanding`	956.00M	shares	Annual
Anti-dilutive shares excluded from the calculation of dilutive effect of common share equivalents	`AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount`	1.00M	shares	Annual
Anti-dilutive shares excluded from the calculation of dilutive effect of common share equivalents	`AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount`	3.00M	shares	Annual
Anti-dilutive shares excluded from the calculation of dilutive effect of common share equivalents	`AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount`	6.00M	shares	Annual

Cash Flow Statement 111 line items

Line Item	Tag	Value	Unit	Period
Net earnings	`ProfitLoss`	$17.73B	USD	Annual
Net earnings	`ProfitLoss`	$20.64B	USD	Annual
Net earnings	`ProfitLoss`	$23.14B	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$3.97B	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$3.40B	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$3.10B	USD	Annual
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-673.00M	USD	Annual
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-245.00M	USD	Annual
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$130.00M	USD	Annual
Share-based compensation	`ShareBasedCompensation`	$925.00M	USD	Annual
Share-based compensation	`ShareBasedCompensation`	$800.00M	USD	Annual
Share-based compensation	`ShareBasedCompensation`	$1.06B	USD	Annual
Other, net	`OtherNoncashIncomeExpense`	$505.00M	USD	Annual
Other, net	`OtherNoncashIncomeExpense`	$944.00M	USD	Annual
Other, net	`OtherNoncashIncomeExpense`	$331.00M	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$3.11B	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$2.52B	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$1.00B	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$2.44B	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$1.37B	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$1.03B	USD	Annual
Medical costs payable	`IncreaseDecreaseInHealthCareInsuranceLiabilities`	$2.70B	USD	Annual
Medical costs payable	`IncreaseDecreaseInHealthCareInsuranceLiabilities`	$4.05B	USD	Annual
Medical costs payable	`IncreaseDecreaseInHealthCareInsuranceLiabilities`	$3.48B	USD	Annual
Accounts payable and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$3.52B	USD	Annual
Accounts payable and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$1.96B	USD	Annual
Accounts payable and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$1.16B	USD	Annual
Unearned revenues	`IncreaseDecreaseInDeferredRevenue`	$126.00M	USD	Annual
Unearned revenues	`IncreaseDecreaseInDeferredRevenue`	$203.00M	USD	Annual
Unearned revenues	`IncreaseDecreaseInDeferredRevenue`	$-310.00M	USD	Annual
Cash flows from operating activities	`NetCashProvidedByUsedInOperatingActivities`	$22.34B	USD	Annual
Cash flows from operating activities	`NetCashProvidedByUsedInOperatingActivities`	$26.21B	USD	Annual
Cash flows from operating activities	`NetCashProvidedByUsedInOperatingActivities`	$29.07B	USD	Annual
Purchases of investments	`PaymentsToAcquireInvestments`	$17.14B	USD	Annual
Purchases of investments	`PaymentsToAcquireInvestments`	$18.82B	USD	Annual
Purchases of investments	`PaymentsToAcquireInvestments`	$18.31B	USD	Annual
Sales of investments	`ProceedsFromSaleOfAvailableForSaleSecuritiesDebt`	$5.91B	USD	Annual
Sales of investments	`ProceedsFromSaleOfAvailableForSaleSecuritiesDebt`	$7.31B	USD	Annual
Sales of investments	`ProceedsFromSaleOfAvailableForSaleSecuritiesDebt`	$7.04B	USD	Annual
Maturities of investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$9.23B	USD	Annual
Maturities of investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$8.25B	USD	Annual
Maturities of investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$6.08B	USD	Annual
Cash paid for acquisitions, net of cash assumed	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$10.14B	USD	Annual
Cash paid for acquisitions, net of cash assumed	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$4.82B	USD	Annual
Cash paid for acquisitions, net of cash assumed	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$21.46B	USD	Annual
Purchases of property, equipment and capitalized software	`PaymentsToAcquirePropertyPlantAndEquipment`	$2.45B	USD	Annual
Purchases of property, equipment and capitalized software	`PaymentsToAcquirePropertyPlantAndEquipment`	$2.80B	USD	Annual
Purchases of property, equipment and capitalized software	`PaymentsToAcquirePropertyPlantAndEquipment`	$3.39B	USD	Annual
Cash received from dispositions	`ProceedsFromDivestitureOfBusinesses`	$15.00M	USD	Annual
Cash received from dispositions	`ProceedsFromDivestitureOfBusinesses`	$3.41B	USD	Annual
Cash received from dispositions	`ProceedsFromDivestitureOfBusinesses`	$685.00M	USD	Annual
Other, net	`PaymentsForProceedsFromOtherInvestingActivities`	$1.27B	USD	Annual
Other, net	`PaymentsForProceedsFromOtherInvestingActivities`	$960.00M	USD	Annual
Other, net	`PaymentsForProceedsFromOtherInvestingActivities`	$793.00M	USD	Annual
Cash flows used for investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-10.37B	USD	Annual
Cash flows used for investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-28.48B	USD	Annual
Cash flows used for investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-15.57B	USD	Annual
Common share repurchases	`PaymentsForRepurchaseOfCommonStock`	$8.00B	USD	Annual
Common share repurchases	`PaymentsForRepurchaseOfCommonStock`	$7.00B	USD	Annual
Common share repurchases	`PaymentsForRepurchaseOfCommonStock`	$5.00B	USD	Annual
Cash dividends paid	`PaymentsOfDividendsCommonStock`	$5.28B	USD	Annual
Cash dividends paid	`PaymentsOfDividendsCommonStock`	$1.74B	USD	Point-in-time
Cash dividends paid	`PaymentsOfDividendsCommonStock`	$1.54B	USD	Point-in-time
Cash dividends paid	`PaymentsOfDividendsCommonStock`	$1.74B	USD	Point-in-time
Cash dividends paid	`PaymentsOfDividendsCommonStock`	$1.75B	USD	Point-in-time
Cash dividends paid	`PaymentsOfDividendsCommonStock`	$5.99B	USD	Annual
Cash dividends paid	`PaymentsOfDividendsCommonStock`	$6.76B	USD	Annual
Proceeds from common stock issuances	`ProceedsFromIssuanceOfCommonStock`	$1.35B	USD	Annual
Proceeds from common stock issuances	`ProceedsFromIssuanceOfCommonStock`	$1.25B	USD	Annual
Proceeds from common stock issuances	`ProceedsFromIssuanceOfCommonStock`	$1.35B	USD	Annual
Repayments of long-term debt	`RepaymentsOfLongTermDebt`	$3.15B	USD	Annual
Repayments of long-term debt	`RepaymentsOfLongTermDebt`	$3.02B	USD	Annual
Repayments of long-term debt	`RepaymentsOfLongTermDebt`	$2.12B	USD	Annual
Proceeds from (repayments of) short-term borrowings, net	`ProceedsFromRepaymentsOfCommercialPaper`	$732.00M	USD	Annual
Proceeds from (repayments of) short-term borrowings, net	`ProceedsFromRepaymentsOfCommercialPaper`	$11.00M	USD	Annual
Proceeds from (repayments of) short-term borrowings, net	`ProceedsFromRepaymentsOfCommercialPaper`	$-1.30B	USD	Annual
Proceeds from issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$6.39B	USD	Annual
Proceeds from issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$14.82B	USD	Annual
Proceeds from issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$6.93B	USD	Annual
Customer funds administered	`IncreaseDecreaseInDeposits`	$622.00M	USD	Annual
Customer funds administered	`IncreaseDecreaseInDeposits`	$5.55B	USD	Annual
Customer funds administered	`IncreaseDecreaseInDeposits`	$-521.00M	USD	Annual
Purchases of redeemable noncontrolling interests	`PaymentsForRepurchaseOfRedeemableNoncontrollingInterest`	$1.34B	USD	Annual
Purchases of redeemable noncontrolling interests	`PaymentsForRepurchaseOfRedeemableNoncontrollingInterest`	$176.00M	USD	Annual
Purchases of redeemable noncontrolling interests	`PaymentsForRepurchaseOfRedeemableNoncontrollingInterest`	$730.00M	USD	Annual
Other, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$-1.15B	USD	Annual
Other, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$-295.00M	USD	Annual
Other, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$-1.94B	USD	Annual
Cash flows (used for) from financing activities	`NetCashProvidedByUsedInFinancingActivities`	$4.23B	USD	Annual
Cash flows (used for) from financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-11.53B	USD	Annual
Cash flows (used for) from financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-7.46B	USD	Annual
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$97.00M	USD	Annual
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$34.00M	USD	Annual
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-62.00M	USD	Annual
Increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$1.99B	USD	Annual
Increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$4.45B	USD	Annual
Increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$2.06B	USD	Annual
Cash and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$21.38B	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$25.43B	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$16.92B	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$23.36B	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$21.38B	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$25.43B	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$16.92B	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$23.36B	USD	Point-in-time
Cash paid for interest	`InterestPaidNet`	$1.95B	USD	Annual
Cash paid for interest	`InterestPaidNet`	$3.04B	USD	Annual
Cash paid for interest	`InterestPaidNet`	$1.65B	USD	Annual
Cash paid for income taxes	`IncomeTaxesPaidNet`	$5.22B	USD	Annual
Cash paid for income taxes	`IncomeTaxesPaidNet`	$6.08B	USD	Annual
Cash paid for income taxes	`IncomeTaxesPaidNet`	$3.97B	USD	Annual

Stockholders Equity 51 line items

Line Item	Tag	Value	Unit	Period
Cash dividends per common share	`CommonStockDividendsPerShareCashPaid`	$7.29	USD	Annual
Cash dividends per common share	`CommonStockDividendsPerShareCashPaid`	$1.88	USD	Point-in-time
Cash dividends per common share	`CommonStockDividendsPerShareCashPaid`	$1.65	USD	Point-in-time
Cash dividends per common share	`CommonStockDividendsPerShareCashPaid`	$6.40	USD	Annual
Cash dividends per common share	`CommonStockDividendsPerShareCashPaid`	$1.88	USD	Point-in-time
Cash dividends per common share	`CommonStockDividendsPerShareCashPaid`	$1.88	USD	Point-in-time
Cash dividends per common share	`CommonStockDividendsPerShareCashPaid`	$5.60	USD	Annual
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$68.33B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$81.45B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$94.42B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$75.05B	USD	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	924.00M	shares	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	934.00M	shares	Point-in-time
Net earnings attributable to UnitedHealth Group common shareholders	`NetIncomeLoss`	$22.38B	USD	Annual
Net earnings attributable to UnitedHealth Group common shareholders	`NetIncomeLoss`	$20.12B	USD	Annual
Net earnings attributable to UnitedHealth Group common shareholders	`NetIncomeLoss`	$17.29B	USD	Annual
Net earnings, Including Portion Attributable to Nonredeemable Noncontrolling Interest	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$20.53B	USD	Annual
Net earnings, Including Portion Attributable to Nonredeemable Noncontrolling Interest	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$22.96B	USD	Annual
Net earnings, Including Portion Attributable to Nonredeemable Noncontrolling Interest	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$17.64B	USD	Annual
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-3.01B	USD	Annual
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-1.57B	USD	Annual
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$1.37B	USD	Annual
Issuances of common stock, and related tax effects	`StockIssuedDuringPeriodValueNewIssues`	$1.10B	USD	Annual
Issuances of common stock, and related tax effects	`StockIssuedDuringPeriodValueNewIssues`	$1.23B	USD	Annual
Issuances of common stock, and related tax effects	`StockIssuedDuringPeriodValueNewIssues`	$903.00M	USD	Annual
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$729.00M	USD	Annual
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$875.00M	USD	Annual
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$1.03B	USD	Annual
Common share repurchases (in shares)	`StockRepurchasedAndRetiredDuringPeriodShares`	16.00M	shares	Annual
Common share repurchases (in shares)	`StockRepurchasedAndRetiredDuringPeriodShares`	14.00M	shares	Annual
Common share repurchases	`StockRepurchasedAndRetiredDuringPeriodValue`	$7.00B	USD	Annual
Common share repurchases	`StockRepurchasedAndRetiredDuringPeriodValue`	$5.00B	USD	Annual
Common share repurchases	`StockRepurchasedAndRetiredDuringPeriodValue`	$8.06B	USD	Annual
Cash dividends paid on common shares ($7.29 per share, $6.40 per share and $5.60 per share for the years ended December 31, 2023, 2022 and 2021, respectively)	`DividendsCash`	$5.99B	USD	Annual
Cash dividends paid on common shares ($7.29 per share, $6.40 per share and $5.60 per share for the years ended December 31, 2023, 2022 and 2021, respectively)	`DividendsCash`	$5.28B	USD	Annual
Cash dividends paid on common shares ($7.29 per share, $6.40 per share and $5.60 per share for the years ended December 31, 2023, 2022 and 2021, respectively)	`DividendsCash`	$6.76B	USD	Annual
Redeemable noncontrolling interests fair value and other adjustments	`MinorityInterestChangeInRedemptionValue`	$-114.00M	USD	Annual
Redeemable noncontrolling interests fair value and other adjustments	`MinorityInterestChangeInRedemptionValue`	$995.00M	USD	Annual
Redeemable noncontrolling interests fair value and other adjustments	`MinorityInterestChangeInRedemptionValue`	$201.00M	USD	Annual
Acquisition and other adjustments of nonredeemable noncontrolling interests	`NoncontrollingInterestIncreaseFromBusinessCombination`	$1.93B	USD	Annual
Acquisition and other adjustments of nonredeemable noncontrolling interests	`NoncontrollingInterestIncreaseFromBusinessCombination`	$374.00M	USD	Annual
Acquisition and other adjustments of nonredeemable noncontrolling interests	`NoncontrollingInterestIncreaseFromBusinessCombination`	$407.00M	USD	Annual
Distributions to nonredeemable noncontrolling interests	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$387.00M	USD	Annual
Distributions to nonredeemable noncontrolling interests	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$516.00M	USD	Annual
Distributions to nonredeemable noncontrolling interests	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$319.00M	USD	Annual
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$68.33B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$81.45B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$94.42B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$75.05B	USD	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	924.00M	shares	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	934.00M	shares	Point-in-time

Comprehensive Income 36 line items

Line Item	Tag	Value	Unit	Period
Net earnings	`ProfitLoss`	$17.73B	USD	Annual
Net earnings	`ProfitLoss`	$20.64B	USD	Annual
Net earnings	`ProfitLoss`	$23.14B	USD	Annual
Gross unrealized gains (losses) on investment securities during the period	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$1.14B	USD	Annual
Gross unrealized gains (losses) on investment securities during the period	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$-4.29B	USD	Annual
Gross unrealized gains (losses) on investment securities during the period	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$-1.03B	USD	Annual
Income tax effect	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	$-984.00M	USD	Annual
Income tax effect	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	$-248.00M	USD	Annual
Income tax effect	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	$263.00M	USD	Annual
Total unrealized gains (losses), net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-3.31B	USD	Annual
Total unrealized gains (losses), net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-780.00M	USD	Annual
Total unrealized gains (losses), net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$876.00M	USD	Annual
Gross reclassification adjustment for net realized (gains) losses included in net earnings	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax`	$-139.00M	USD	Annual
Gross reclassification adjustment for net realized (gains) losses included in net earnings	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax`	$173.00M	USD	Annual
Gross reclassification adjustment for net realized (gains) losses included in net earnings	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax`	$90.00M	USD	Annual
Income tax effect	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax`	$-32.00M	USD	Annual
Income tax effect	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax`	$40.00M	USD	Annual
Income tax effect	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax`	$21.00M	USD	Annual
Total reclassification adjustment, net of tax	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax`	$69.00M	USD	Annual
Total reclassification adjustment, net of tax	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax`	$133.00M	USD	Annual
Total reclassification adjustment, net of tax	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax`	$-107.00M	USD	Annual
Total foreign currency translation gains (losses)	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$192.00M	USD	Annual
Total foreign currency translation gains (losses)	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-657.00M	USD	Annual
Total foreign currency translation gains (losses)	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$559.00M	USD	Annual
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-3.01B	USD	Annual
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-1.57B	USD	Annual
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$1.37B	USD	Annual
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$16.16B	USD	Annual
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$24.51B	USD	Annual
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$17.63B	USD	Annual
Comprehensive income attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$447.00M	USD	Annual
Comprehensive income attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$763.00M	USD	Annual
Comprehensive income attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$519.00M	USD	Annual
Comprehensive income attributable to UnitedHealth Group common shareholders	`ComprehensiveIncomeNetOfTax`	$15.71B	USD	Annual
Comprehensive income attributable to UnitedHealth Group common shareholders	`ComprehensiveIncomeNetOfTax`	$17.11B	USD	Annual
Comprehensive income attributable to UnitedHealth Group common shareholders	`ComprehensiveIncomeNetOfTax`	$23.75B	USD	Annual

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.